Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolysis Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00874172
What this trial is testing

Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy

Who this might be right for
Sickle Cell Anemia
Assistance Publique - Hôpitaux de Paris 176
Not applicableLooking for participantsNCT06923111
What this trial is testing

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]

Who this might be right for
Sickle Cell Disease
Nova Laboratories Limited 180
Not applicableStudy completedNCT03919812
What this trial is testing

Immunomodulatory Vitamin D in Thalassemia

Who this might be right for
ThalassemiaTuberculosisVitamin D Deficiency
Universitas Padjadjaran 60
Not applicableLooking for participantsNCT06271512
What this trial is testing

Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 150
Large-scale testing (Phase 3)Study completedNCT01142219
What this trial is testing

L-Arginine and Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Hospital de Clinicas de Porto Alegre 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06989567
What this trial is testing

Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis

Who this might be right for
Sickle Cell Disease
Asklepion Pharmaceuticals, LLC 120
Testing effectiveness (Phase 2)Study completedNCT00029731
What this trial is testing

Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

Who this might be right for
Anemia, Sickle CellPneumonia
UCSF Benioff Children's Hospital Oakland 30
Large-scale testing (Phase 3)UnknownNCT02083575
What this trial is testing

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Who this might be right for
Vitamin cThalassemia MajorIron Chelation
Ain Shams University 50
Early research (Phase 1)Study completedNCT03926819
What this trial is testing

Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 20
Not applicableStudy completedNCT03069430
What this trial is testing

A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I

Who this might be right for
Anemia, Sickle Cell
Medical University of South Carolina 44
Not applicableLooking for participantsNCT04398628
What this trial is testing

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Who this might be right for
Hematologic DisorderBleeding DisorderConnective Tissue Disorder+10 more
American Thrombosis and Hemostasis Network 3,000
Not applicableEnded earlyNCT00578292
What this trial is testing

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

Who this might be right for
Thalassemia
Baylor College of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT03401112
What this trial is testing

IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)

Who this might be right for
Sickle Cell Disease
Cardurion Pharmaceuticals, Inc. 100
Not applicableUnknownNCT04264871
What this trial is testing

Is the Preoperative Preparation of Sickle Cell Patients Optimal: Assessment of Practices and Post-operative Complications

Who this might be right for
Sickle Cell Disease
Queen Fabiola Children's University Hospital 250
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Not applicableStudy completedNCT03161899
What this trial is testing

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Who this might be right for
Thalassemia Major
Assiut University 246
Not applicableStudy completedNCT03977532
What this trial is testing

Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Assistance Publique Hopitaux De Marseille 21
Testing effectiveness (Phase 2)Study completedNCT00029393
What this trial is testing

Induction of Stable Chimerism for Sickle Cell Anemia

Who this might be right for
Blood DiseaseHematopoietic Stem Cell TransplantationAnemia, Sickle Cell
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT02447874
What this trial is testing

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 21
Next Page